Markets /Healthcare /GLS Gelesis Holdings, Inc. GLS Full chart Compare Add to watchlist Set alert Price alert · GLS Alert when the price is Price abovePrice below Price level Set alert All alert types 0.16 +0.16 Day range unavailable 52-week range unavailable Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2022FY 2021 Other Income → Expenses: $66.51MExpenses → Gross Loss: $1.79MExpenses → Selling, General & Admin: $99.14MExpenses → Research & Development: $18.61MExpenses → Other Operating Expenses: $2.27MExpenses → Income Tax: $480.00KNet Loss → Expenses: $55.78MRevenue → Cost of Revenue: $25.77MOther Income$66.51MNet Loss$55.78MCost of Revenue$27.56MExpenses$122.29MGross Loss$1.79MSelling, General & Admin$99.14MResearch & Development$18.61MOther Operating Expenses$2.27MIncome Tax$480.00KRevenue$25.77M No annual statement lines GLS has no annual lines for this statement.
